0

Journal Articles

in Percutaneous Coronary Intervention
 21-40 of 80 Articles
Commentary |  November 10, 2010
Putting Ad Hoc PCI on Pause
Brahmajee K. Nallamothu, MD, MPH; Harlan M. Krumholz, MD, SM
JAMA. 2010;304(18):2059-2060. doi:10.1001/jama.2010.1509.
Medical News and Perspectives |  November 10, 2010
Patients Fail to Grasp That PCI Reduces Angina But Not Myocardial Infarction Risk
Mike Mitka
JAMA. 2010;304(18):2000. doi:10.1001/jama.2010.1604.
Original Contribution |  November 10, 2010 FREE
Automated Surveillance to Detect Postprocedure Safety Signals of Approved Cardiovascular Devices
Frederic S. Resnic, MD, MSc; Thomas P. Gross, MD, MPH; Danica Marinac-Dabic, MD, PhD; et al.
JAMA. 2010;304(18):2019-2027. doi:10.1001/jama.2010.1633.
INCLUDES: , Supplemental Content
Original Contribution |  September 22, 2010 FREE
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux:  The FUTURA/OASIS-8 Randomized Trial
The FUTURA/OASIS-8 Trial Group*
JAMA. 2010;304(12):1339-1349. doi:10.1001/jama.2010.1320.
INCLUDES: , Supplemental Content
Original Contribution |  August 25, 2010 FREE
Elective Intra-aortic Balloon Counterpulsation During High-Risk Percutaneous Coronary Intervention:  A Randomized Controlled Trial
Divaka Perera, MD, MRCP; Rodney Stables, DM, FRCP; Martyn Thomas, MD, FRCP; et al.
JAMA. 2010;304(8):867-874. doi:10.1001/jama.2010.1190.
Original Contribution |  August 18, 2010 FREE
System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention
Christian Juhl Terkelsen, MD, PhD; Jacob Thorsted Sørensen, MD; Michael Maeng, MD, PhD; et al.
JAMA. 2010;304(7):763-771. doi:10.1001/jama.2010.1139.
Original Contribution |  June 02, 2010 FREE
Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention
Steven P. Marso, MD; Amit P. Amin, MD; John A. House, MS; et al.
JAMA. 2010;303(21):2156-2164. doi:10.1001/jama.2010.708.
INCLUDES: , Supplemental Content
Original Contribution |  December 09, 2009 FREE
Contraindicated Medication Use in Dialysis Patients Undergoing Percutaneous Coronary Intervention
Thomas T. Tsai, MD, MSc; Thomas M. Maddox, MD, MSc; Matthew T. Roe, MD, MHS; et al.
JAMA. 2009;302(22):2458-2464. doi:10.1001/jama.2009.1800.
Commentary |  August 19, 2009
Registries for Robust Evidence
Nancy A. Dreyer, PhD; Sarah Garner, PhD
JAMA. 2009;302(7):790-791. doi:10.1001/jama.2009.1092.
Original Contribution |  May 06, 2009 FREE
Incidence of and Outcomes Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention
Rajendra H. Mehta, MD, MS; Aijing Z. Starr, MS; Renato D. Lopes, MD, PhD; et al.
JAMA. 2009;301(17):1779-1789. doi:10.1001/jama.2009.600.
Medical News & Perspectives |  November 05, 2008
Direct-to-Consumer Advertising of Medical Devices Under Scrutiny
Mike Mitka
JAMA. 2008;300(17):1985-1986. doi:10.1001/jama.2008.528.
Original Contribution |  October 15, 2008 FREE
Frequency of Stress Testing to Document Ischemia Prior to Elective Percutaneous Coronary Intervention
Grace A. Lin, MD, MAS; R. Adams Dudley, MD, MBA; F. L. Lucas, PhD; et al.
JAMA. 2008;300(15):1765-1773. doi:10.1001/jama.300.15.1765.
Original Contribution |  June 25, 2008 FREE
Outcomes Following Coronary Stenting in the Era of Bare-Metal vs the Era of Drug-Eluting Stents
David J. Malenka, MD; Aaron V. Kaplan, MD; F. Lee Lucas, PhD; et al.
JAMA. 2008;299(24):2868-2876. doi:10.1001/jama.299.24.2868.
Original Contribution |  January 30, 2008 FREE
Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical Practice:  The SORT OUT II Randomized Trial
Anders M. Galløe, MD; Leif Thuesen, MD; Henning Kelbæk, MD; et al.
JAMA. 2008;299(4):409-416. doi:10.1001/jama.299.4.409.
Editorial |  December 19, 2007
Measuring the Quality of Primary PCI for ST-Segment Elevation Myocardial Infarction:  Time for Balance
Frederick A. Masoudi, MD, MSPH
JAMA. 2007;298(23):2790-2791. doi:10.1001/jama.298.23.2790.
Original Contribution |  November 28, 2007 FREE
Implementation of a Statewide System for Coronary Reperfusion for ST-Segment Elevation Myocardial Infarction
James G. Jollis, MD; Mayme L. Roettig, RN, MSN; Akinyele O. Aluko, MD; et al.
JAMA. 2007;298(20):2371-2380. doi:10.1001/jama.298.20.joc70124.
Editorial |  May 09, 2007
The Enigma of Drug-Eluting Stents:  Hope, Hype, Humility, and Advancing Patient Care
Robert A. Harrington, MD; E. Magnus Ohman, MD
JAMA. 2007;297(18):2028-2030. doi:10.1001/jama.297.18.2028.
Original Contribution |  May 09, 2007 FREE
Outcomes and Complications Associated With Off-Label and Untested Use of Drug-Eluting Stents
Nirat Beohar, MD; Charles J. Davidson, MD; Kevin E. Kip, PhD; et al.
JAMA. 2007;297(18):1992-2000. doi:10.1001/jama.297.18.1992.
Original Contribution |  May 09, 2007 FREE
Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction:  The SWISSI II Randomized Controlled Trial
Paul Erne, MD; Andreas W. Schoenenberger, MD; Dieter Burckhardt, MD; et al.
JAMA. 2007;297(18):1985-1991. doi:10.1001/jama.297.18.1985.
Original Contribution |  February 14, 2007 FREE
Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes:  The ACUITY Timing Trial
Gregg W. Stone, MD; Michel E. Bertrand, MD; Jeffrey W. Moses, MD; et al.
JAMA. 2007;297(6):591-602. doi:10.1001/jama.297.6.591.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  Oct 2012
Initial Experience With Hyperthermic Intraperitoneal Chemotherapy
Olivier Turrini, MD; Eric Lambaudie, MD; Marion Faucher, MD; et al.
JAMA Internal Medicine
Invited Commentary  |  Aug 13/27, 2012
How Drug-Eluting Stents Illustrate Our Health System's Flawed Relationship With Technology:  Comment on “Use of Drug-Eluting Stents as a Function of Predicted Benefit”
Peter W. Groeneveld, MD, MS
JAMA Internal Medicine
Original Investigation  |  Aug 13/27, 2012
Use of Drug-Eluting Stents as a Function of Predicted Benefit:  Clinical and Economic Implications of Current Practice
Amit P. Amin, MD, MSc; John A. Spertus, MD, MPH; David J. Cohen, MD, MSc; et al.
JAMA Internal Medicine
Editor's Correspondence  |  July 9, 2012
Percutaneous Coronary Intervention for Stable Coronary Artery Disease: The Debate Continues
Elvis A. Peter, MD; Nuri I. Akkus, MD; Jai Varma, MD, FSCAI
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems